SEARCH

SEARCH BY CITATION

References

  • 1
    Ramirez MA. Horse asthma following blood transfusion. JAMA 1919;73: 984.
  • 2
    Loveless MH. Immunological studies of pollinosis. II. Passive sensitization of man through transfusion. J Immunol 1941;41: 1534.
  • 3
    Garver WP. The transference of reagins in blood. J Allergy 1939;11: 32.
  • 4
    Routledge RC, de Kretser DMH, Wadsworth LD. Severe anaphylaxis due to passive sensitisation by donor blood. Brit Med J 1976;1: 434.
  • 5
    Stern A, van Hage-Hamsten M, Sondell K, Johansson SGO. Is allergy screening of blood donors necessary? Vox Sang 1995;69: 114119.
  • 6
    Bennich HH, Ishizaka K, Johansson SGO, Rowe DS, Stanworth DR, Terry WD. Immunoglobulin E, a new class of human immunoglobulin. Bull World Health Organ 1968;38: 151152.
  • 7
    Kirshbaum BA, Cohen HB, Beerman H, Pastras T. The basophil degranulation test. A review of the literature. Am J Med Sci 1967;253: 473492.
  • 8
    Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991;88: 328338.
  • 9
    Bühring H-J, Simmons PJ, Pudney M, Müller R, Jarrossay D, van Agthoven A et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 1999;94: 23432356.
  • 10
    Cozon GJN, Ferrándiz J, Peyramond D, Brunet JL. Detection of activated basophils using flow cytometry for diagnosis in atopic patients. Allergol et Immunopathol 1999;27: 182187.
  • 11
    Bennich H, Johansson SGO. Structure and function of human Immunoglobulin E. Adv Immunol 1971;13: 155.
  • 12
    Waldmann TA. Disorders of immunoglobulin metabolism. N Engl J Med 1969;281: 11701177.
  • 13
    Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001;107: 891896.
  • 14
    Litvyakova LI, Baraniuk JN. Human nasal allergen provocation of true allergic rhinitis: methods for clinicians. Curr Allergy Asthma Rep 2002;2: 194202.
  • 15
    Vohlonen I, Terho EO, Koivikko A, Vanto T, Holmen A, Heinonen OP. Reproducibility of the skin prick test. Allergy 1989;44: 525531.
  • 16
    Casalaro V, Spadaro G, Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990;142: 11081111.
  • 17
    Hemery M-L, Arnoux B, Dhivert-Donnadieu H, Rongier M, Barbotte E, Verdier R et al. Confirmation of the diagnosis of natural rubber latex allergy by the Basotest® method. Int Arch Allergy Immunol 2005;136: 5357.
  • 18
    Sanz ML, Gamboa P, De Weck AL. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;136: 5872.
  • 19
    Macglashan D. Loss of receptors and IgE in vivo during treatment with anti-IgE antibody. J Allergy Clin Immunol 2004;114: 14721474.
  • 20
    Hill MR, Cookson WOCM. A new variant of the β subunit of the high-affinity receptor for immunoglobulin E (FcɛRI-β E237G): associations with measures of atopy and bronchial hyper-responsiveness. Human Mol Genet 1996;5: 959962.
  • 21
    Macglashan DW Jr, Schroeder JT, Lichtenstein LM, Saini SS, Bochner B. Mediator release from basophils and mast cells and its relationship to FcɛRI expression and IgE-suppression therapies. In: FickRB, JardieuPM, editors. IgE and Anti-IgE Therapy in Asthma and Allergic Disease. New York: Marcel Dekker Inc., 2002: 3968.
  • 22
    Augustin R. Demonstration of reagins in the serum of allergic subjects. In: WeirDM, editor. Handbook of Experimental Immunology. Oxford and Edinburgh: Blackwell Scientific Publications, 1967: 10761151.
  • 23
    Beck LA, Marcotte GV, Macglashan D Jr, Togias A, Saini S. Omalizumab-induced reductions in mast cell FcɛRI expression and function. J Allergy Clin Immunol 2004;114: 527530.
  • 24
    Lin H, Boesel KM, Griffith DT, Prussin C, Foster B, Romero FA et al. Omalizumab rapidly decreases nasal allergic response and FcɛRI on basophils. J Allergy Clin Immunol 2004;113: 297302.
  • 25
    Marchand F, Mecheri S, Guilloux L, Iannascoli B, Weyer A, Blank U. Human serum IgE-mediated mast cell degranulation shows poor correlation to allergen-specific IgE content. Allergy 2003;58: 10371043.